Fund HoldingsSands Capital Alternatives, LLC

Total Portfolio Value
$507.82M
Total Bought
$107.01M
Total Sold
$4.13M
Net Transaction
+$102.88M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
NU HLDGS LTD(NU)7,164,3557,175,434+11,07973,36398,44719.39%+25,084
DOORDASH INC(DASH)380,704381,202+49869,58193,97018.50%+24,389
BETA BIONICS INC3,103,7823,570,113+466,33137,99051,98110.24%+13,991
KLAVIYO INC(KVYO)3,443,5153,515,065+71,550104,201118,03623.24%+13,835
SAMSARA INC(IOT)253,432438,485+185,0539,71417,4433.43%+7,729
COUPANG INC(CPNG)843,476849,031+5,55518,49725,4375.01%+6,940
MONDAY COM LTD
SHS
49,90858,336+8,42812,13618,3463.61%+6,210
DATADOG INC(DDOG)117,930118,707+77711,70015,9463.14%+4,246
CROWDSTRIKE HLDGS INC(CRWD)15,56015,615+555,4867,9531.57%+2,467
SNOWFLAKE INC(SNOW)26,82827,005+1773,9216,0431.19%+2,122
10X GENOMICS INC(TXG)481,770481,77004,2065,5791.10%+1,373
TAYSHA GENE THERAPIES INC(TSHA)724,873724,87301,0081,6740.33%+667
BIOAGE LABS INC(BIOA)786,353786,35302,9573,2480.64%+291
ACUMEN PHARMACEUTICALS INC3,417,0753,417,07503,7593,9640.78%+205
TOAST INC(TOST)210,611156,604-54,0076,9866,9361.37%-50
CANDEL THERAPEUTICS INC405,837405,83702,2932,0540.40%-239
ACRIVON THERAPEUTICS INC2,122,6052,122,60504,3092,5260.50%-1,783
TARSUS PHARMACEUTICALS INC(TARS)170,000170,00008,7336,8871.36%-1,846
INHIBIKASE THERAPEUTICS INC10,950,00010,950,000023,98121,3534.20%-2,628
UIPATH INC(PATH)395,8550-395,8554,0770-4,077
Page 1 of 1